Atlas Trials

Bioequivalence Study of Amoxicillin-Clavulanic Acid 600 mg - 42.9 mg/ 5 mL Oral Suspension Under Fasting Conditions

Clinical trial NCT00778414 · COMPLETED

Trial details

NCT number
NCT00778414
Sponsor
Ranbaxy Laboratories Limited
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Healthy
Start date
2006-06-01
Primary completion
2006-07-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.